Healio

FDA expands Klisyri approval for actinic keratosis treatment on larger face, scalp areas

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the expanded use area of Klisyri to up to 100 cm 2 on the face and scalp for the treatment ...
Medscape

Tirbanibulin 1% Safe, Well-Tolerated in Extensive Actinic Keratosis

Tirbanibulin ointment 1% shows good safety and tolerability in the treatment of actinic keratosis (AK) in fields of up to 100 cm 2 on the face and scalp. The most common local effects of treatment ...
clinicaladvisor.com

New option for actinic keratosis

Pharmacology: The mechanism of action by which ingenol mebutate induces cell death in treating actinic keratosis lesions is unknown. Clinical trials: In two double-blind, vehicle-controlled, clinical ...
Healio

FDA approves increase of Ameluz dosing from one to three tubes for actinic keratosis

Please provide your email address to receive an email when new articles are posted on . The supplemental new drug application approved for Ameluz topical gel 10% increases the maximal dose from one to ...
Business Insider

Almirall receives positive CHMP opinion for Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis

BARCELONA, Spain, May 21, 2021 /PRNewswire/ -- Almirall S.A. (BME: ALM), a global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...
Business Wire

Vidac Pharma Reports Positive Results from Phase 2a Proof-of-Concept Trial of VDA-1102 Ointment in Actinic Keratosis

The randomized, double-blind, placebo-controlled, parallel-cohort Phase 2a clinical trial investigated the efficacy, safety, tolerability, and pharmacokinetics of once-daily application of topical VDA ...
Medscape

FDA Approves Expansion of Treatment Area for Actinic Keratosis Treatment

The US Food and Drug Administration has approved a supplemental new drug application for tirbanibulin topical ointment, allowing the expansion of the surface area treated for actinic keratosis (AK) of ...
Monthly Prescribing Reference

FDA Approves Dosage Increase for Actinic Keratosis Treatment Ameluz

The new approval allows for use of up to 3 tubes of Ameluz per treatment. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application for Ameluz ® (aminolevulinic acid ...
Nasdaq

Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines Agency (EMA) for the Treatment of Actinic Keratosis of the Face or Scalp

BUFFALO, N.Y., May 21, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for ...
Seeking Alpha

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint

WOBURN, Mass., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...
Business Insider

Almirall receives positive CHMP opinion for Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis

- Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) and it acts through a selective antiproliferative mechanism of action - The ...